This webcast will discuss how cold storage strategy can affect cell viability, genetic material stability, chain-of-custody expectations, and operational readiness in research and clinical manufacturing environments, including the latest regulatory requirements. Attendees will gain insight into best practices for storing and monitoring CGT materials, as well as strategies to mitigate risks such as temperature excursions and contamination.
Learn:
- How ultra-low-temperature storage supports sample integrity across cell and gene therapy workflows
- What storage-related risks can compromise sensitive biological materials, including temperature excursions, contamination, handling variability, and poor monitoring
- Best CGT workflow practices to strengthen storage reliability, documentation, and operational readiness
Cell and gene therapy (CGT) workflows depend on preserving highly sensitive biological materials across collection, processing, storage, distribution, and administration. Because these materials may be affected by temperature instability, repeated handling, contamination risk, and inconsistent monitoring, ultra-low-temperature (UTL) storage is increasingly recognized as a critical part of maintaining sample integrity and supporting reproducible outcomes.